V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220016511 | 220006511 | 1.62 | 96.7 | null | 2013-10-22 | 2013-12-31 | FLAG + Idarubicin | Y | N | 220024783 | FLAG + IDARUBICIN |
| 220016512 | 220006511 | 1.63 | 77.5 | Curative (C) | 2015-02-21 | 2016-06-01 | FLAG + Idarubicin | Y | N | 220024783 | FLAG + IDARUBICIN |
| 220016514 | 220006514 | 1.58 | 63.8 | Radical (R) | 2015-10-20 | 2016-03-17 | FLAG + Idarubicin | 02 | N | 220024790 | FLAG + IDARUBICIN |
| 220016515 | 220006516 | 1.57 | 49 | Curative (C) | 2017-06-09 | 2017-07-25 | AML17 TRIAL | N | N | 220024802 | AML17 TRIAL |
| 220016516 | 220017396 | null | 81.1 | Curative (C) | 2016-06-06 | 2016-06-06 | FLAG + Idarubicin | null | N | 220024807 | FLAG + IDARUBICIN |
| 220016517 | 220006518 | 1.69 | 91.5 | null | 2012-07-18 | 2012-12-23 | FLAG + Idarubicin | N | null | 220024810 | FLAG + IDARUBICIN |
| 220016518 | 220021452 | 1.52 | 64.15 | Curative (C) | 2016-11-02 | 2016-11-05 | FLAG + Idarubicin | N | N | 220024810 | FLAG + IDARUBICIN |
| 220016521 | 220022255 | 1.46 | 82 | Curative (C) | 2016-04-28 | 2016-04-28 | FLAG + Idarubicin | N | N | 220024826 | FLAG + IDARUBICIN |
| 220016522 | 220013560 | 1.78 | null | Adjuvant (A) | 2015-04-08 | 2015-06-25 | AML17 TRIAL | N | N | 220024843 | AML17 TRIAL |
| 220016523 | 220013560 | 1.83 | 79.5 | Curative (C) | 2015-04-06 | 2015-04-06 | FLAG + Idarubicin | null | null | 220024843 | FLAG + IDARUBICIN |
| 220016524 | 220022074 | 1.66 | null | Curative (C) | 2015-02-02 | 2015-02-02 | FLAG + Idarubicin | null | N | 220024847 | FLAG + IDARUBICIN |
| 220016525 | 220022340 | null | 59.7 | Curative (C) | 2017-01-08 | 2017-02-19 | AML17 TRIAL | null | null | 220024847 | AML17 TRIAL |
| 220016526 | 220006524 | null | 68 | Curative (C) | 2015-02-20 | 2015-02-20 | AML17 TRIAL | 02 | N | 220024870 | AML17 TRIAL |
| 220016527 | 220006526 | 1.88 | 79.2 | Adjuvant (A) | 2013-09-27 | 2013-09-27 | AML17 TRIAL | 02 | Y | 220024873 | AML17 TRIAL |
| 220016528 | 220006527 | 1.82 | 76 | Adjuvant (A) | 2017-04-15 | 2017-06-01 | AML17 TRIAL | N | N | 220024876 | AML17 TRIAL |
| 220016529 | 220006528 | 1.9 | 54 | Curative (C) | 2015-12-20 | 2015-12-21 | AML17 TRIAL | Y | N | 220024885 | AML17 TRIAL |
| 220016530 | 220006529 | 1.81 | null | Curative (C) | 2014-11-19 | 2015-01-02 | AML17 TRIAL | N | N | 220024897 | AML17 TRIAL |
| 220016531 | 220020773 | null | 54.4 | Disease modification (D) | 2014-10-11 | 2014-10-17 | AML17 TRIAL | 2 | N | 220024903 | AML17 TRIAL |
| 220016532 | 220017403 | 1.64 | 95.1 | Curative (C) | 2015-11-05 | 2015-11-07 | FLAG + Idarubicin | N | N | 220024911 | FLAG + IDARUBICIN |
| 220016533 | 220017403 | 1.76 | 73.9 | Curative (C) | 2018-01-24 | 2018-01-31 | FLAG + Idarubicin | 2 | N | 220024911 | FLAG + IDARUBICIN |
| 220016535 | 220022324 | null | 80 | Not known (9) | null | 2018-03-04 | AML17 TRIAL | N | null | 220024925 | AML17 TRIAL |
| 220016536 | 220006533 | 1.65 | 54.6 | Disease modification (D) | 2017-10-30 | 2017-10-30 | AML17 TRIAL | N | N | 220024955 | AML17 TRIAL |
| 220016537 | 220006536 | 1.78 | 77.3 | Curative (C) | 2013-09-15 | 2014-01-19 | AML17 TRIAL | N | N | 220024981 | AML17 TRIAL |
| 220016539 | 220006540 | 1.67 | 97 | Curative (C) | 2017-07-18 | 2017-07-18 | AML17 TRIAL | 02 | N | 220024984 | AML17 TRIAL |
| 220016540 | 220006542 | 1.84 | 58.4 | Curative (C) | null | 2016-11-27 | AML17 TRIAL | N | N | 220024996 | AML17 TRIAL |
| 220016541 | 220017405 | 1.78 | 81.2 | Curative (C) | 2015-11-04 | 2015-11-12 | AML17 TRIAL | 99 | N | 220025003 | AML17 TRIAL |
| 220016542 | 220013572 | 1.71 | 15.4 | Radical (R) | 2015-06-06 | 2015-06-09 | FLAG + Idarubicin | N | N | 220025004 | FLAG + IDARUBICIN |
| 220016543 | 220006545 | 1.68 | 78 | Curative (C) | 2014-10-11 | 2014-10-21 | FLAG + Idarubicin | N | N | 220025010 | FLAG + IDARUBICIN |
| 220016546 | 220006550 | 1.71 | 64 | Curative (C) | 2015-02-17 | 2015-05-07 | AML17 TRIAL | Y | null | 220025042 | AML17 TRIAL |
| 220016547 | 220013576 | null | 60.8 | Curative (C) | 2015-10-10 | 2016-11-01 | AML17 TRIAL | 02 | N | 220025045 | AML17 TRIAL |
| 220016548 | 220006551 | 1.95 | null | Disease modification (D) | 2017-01-16 | 2017-03-23 | AML17 TRIAL | N | N | 220025047 | AML17 TRIAL |
| 220016549 | 220020777 | 1.7 | 69 | Disease modification (D) | 2001-05-25 | 2018-10-16 | FLAG + Idarubicin | 1 | N | 220025048 | FLAG + IDARUBICIN |
| 220016550 | 220006553 | 1.56 | null | Disease modification (D) | 2013-05-27 | 2013-05-27 | AML17 TRIAL | 02 | N | 220025054 | AML17 TRIAL |
| 220016551 | 220006555 | 1.56 | 80.5 | Adjuvant (A) | 2017-07-12 | 2017-07-13 | FLAG + Idarubicin | N | N | 220025062 | FLAG + IDARUBICIN |
| 220016552 | 220006555 | 1.57 | 80.4 | Palliative (P) | 2013-12-19 | 2013-12-19 | FLAG + Idarubicin | N | N | 220025062 | FLAG + IDARUBICIN |
| 220016553 | 220006557 | 1.66 | 64.5 | Disease modification (D) | 2016-04-27 | 2016-05-05 | AML17 TRIAL | N | N | 220025077 | AML17 TRIAL |
| 220016554 | 220006563 | 1.83 | 81.2 | Adjuvant (A) | 2015-12-29 | 2016-01-19 | FLAG + Idarubicin | N | null | 220025096 | FLAG + IDARUBICIN |
| 220016555 | 220006564 | 1.82 | 110 | Adjuvant (A) | 2013-09-14 | 2013-09-28 | FLAG + Idarubicin | 02 | N | 220025103 | FLAG + IDARUBICIN |
| 220016556 | 220017414 | 1.7 | 98 | Curative (C) | 2017-06-07 | 2017-06-12 | FLAG + Idarubicin | N | N | 220025109 | FLAG + IDARUBICIN |
| 220016557 | 220006566 | 1.64 | 86 | null | null | 2016-05-07 | FLAG + Idarubicin | null | N | 220025121 | FLAG + IDARUBICIN |
| 220016558 | 220021461 | 1.67 | 65 | Disease modification (D) | 2016-06-21 | 2016-06-21 | FLAG + Idarubicin | N | N | 220025135 | FLAG + IDARUBICIN |
| 220016559 | 220006571 | 1.5 | 62.7 | Disease modification (D) | 2016-05-25 | 2016-05-25 | AML17 TRIAL | 1 | N | 220025143 | AML17 TRIAL |
| 220016560 | 220006572 | 1.63 | 63.4 | Palliative (P) | null | 2014-01-02 | AML17 TRIAL | N | null | 220025154 | AML17 TRIAL |
| 220016561 | 220006574 | 1.61 | 75.5 | Palliative (P) | 2013-10-24 | 2013-10-31 | AML17 TRIAL | 99 | N | 220025165 | AML17 TRIAL |
| 220016562 | 220017418 | 0 | null | null | 2016-06-06 | 2016-06-06 | AML17 TRIAL | 02 | N | 220025171 | AML17 TRIAL |
| 220016563 | 220006577 | 1.7 | 113 | Disease modification (D) | 2015-08-01 | 2015-08-01 | AML 19 TRIAL | N | N | 220025174 | AML19 TRIAL |
| 220016564 | 220006580 | 1.66 | 56.9 | Not known (9) | 2018-02-12 | 2018-04-16 | Trial Unspecified | null | N | 220025175 | TRIAL |
| 220016565 | 220006582 | 1.8 | 105.3 | Curative (C) | 2016-10-29 | 2016-11-03 | Trial Unspecified | 01 | N | 220025180 | TRIAL |
| 220016566 | 220006584 | 1.62 | 83.6 | Curative (C) | 2016-10-10 | 2017-08-21 | AML 19 TRIAL | null | N | 220025185 | AML19 TRIAL |
| 220016567 | 220006585 | null | 59.5 | Curative (C) | 2017-05-14 | 2017-05-18 | Trial Unspecified | Y | N | 220025218 | TRIAL |